Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A pharmaceutical composition for preventing and treating unstable angina pectoris

A technology for stable angina pectoris and composition, which can be used in drug combinations, active ingredients of hydroxyl compounds, and pharmaceutical formulations, etc., and can solve the problems that drugs are difficult to obtain curative effects and have large side effects.

Active Publication Date: 2021-02-26
GUANGZHOU BAIYUNSHAN PHARMA HLDG CO LTD BAIYUNSHAN PHARMA GENERAL FACTORY
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the pathogenesis of unstable angina involves the abnormality of multiple targets. It is generally difficult to achieve a good curative effect with a single-point drug, and some drugs have disadvantages such as large side effects, so the existing drugs cannot meet the clinical needs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0056] The test drug of this embodiment experimental group is made up of the following components by weight:

[0057] Ginseng 100 parts

[0058] Aconite 50 copies

[0059] Ganoderma lucidum 200 parts

[0060] 150 servings of safflower

[0061] musk 2 parts

[0062] Bear bile 2 servings

[0063] Pearl 100 parts

[0064] Toad Paste 100 parts

[0065] ice flakes 1 serving

[0066] Bezoar 1 part.

Embodiment 2

[0068] The test drug of this embodiment experimental group is made up of the following components by weight:

[0069] Ginseng 600 parts

[0070] Aconite 300 copies

[0071] Ganoderma lucidum 40 servings

[0072] 150 servings of safflower

[0073] Musk 100 parts

[0074] Bear bile 100 parts

[0075] 50 pearls

[0076] Toad cake 50 parts

[0077] borneol 80 servings

[0078] Bezoar 80 parts.

[0079] Example 2

[0080] The test drug of this embodiment experimental group is made up of the following components by weight:

[0081] Ginseng 300 parts

[0082] Aconite 100 copies

[0083] Ganoderma lucidum 80 servings

[0084] 50 servings of safflower

[0085] musk 20 parts

[0086] 40 servings of bear bile

[0087] Pearl 60 servings

[0088] Toad 40 parts

[0089] 10 servings of ice flakes

[0090] Bezoar 10 parts.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to application of a medicine composition in preparation of medicine for preventing and treating unstable angina. The composition is prepared from the following ingredients including radix ginseng, radix aconiti lateralis praeparata, glossy ganoderma, flos carthami, musk, bear gall, pearl, cinobufagin venom toad, borneol and bezoar. The composition can obviously improve the rabbit blood fat level of an unstable angina model; the inflammatory factor release is reduced; the myocardial damage can be reduced; a good curative effect can also be realized on patients with the unstable angina.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to the application of a pharmaceutical composition in the preparation of medicines for preventing and treating unstable angina pectoris. Background technique [0002] With the development of economy and the change of people's diet structure, coronary heart disease, especially acute coronary syndrome (acute coronary syndrome, ACS) has become one of the main diseases that endanger human health in today's society. According to the data of the World Health Organization: In 2002, coronary atherosclerotic heart disease accounted for 12.6% of all deaths in the world, and about 115 people died of ACS in 100,000 people every year. Currently, the economic burden caused by ACS is at the forefront of all diseases. [0003] Among them, unstable angina pectoris (unstable angina, UA) is one of the manifestations of acute coronary syndrome (acutecoronary syndrome, ACS), which has the ch...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/714A61P9/10A61K35/55A61K35/413A61K35/618A61K35/65A61K31/045
CPCA61K31/045A61K35/413A61K35/55A61K35/618A61K35/65A61K36/074A61K36/258A61K36/286A61K36/714A61K2300/00
Inventor 王健松王玮张琳鲍颖霞裴泽健许淑文
Owner GUANGZHOU BAIYUNSHAN PHARMA HLDG CO LTD BAIYUNSHAN PHARMA GENERAL FACTORY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com